PMC:3220857 / 4695-5555 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3220857","sourcedb":"PMC","sourceid":"3220857","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3220857","text":"Study design\nPatients were studied before the start and after completion of the 16-week VLCD. Three weeks before start of the VLCD all oral blood glucose–lowering medication was stopped and insulin therapy was intensified. The day before the start of the VLCD intervention, only short-acting insulin was prescribed. Patients did not use any blood glucose–lowering medication, including insulin, during the 16-week VLCD. The VLCD consisted of three liquid food shakes (Modifast Intensive; provided by Nutrition \u0026 Santé, Antwerp, Belgium) containing a total of 450 kcal/day and all essential micro- and macronutrients. Thirteen of the twenty-seven subjects simultaneously followed an exercise program in addition to the VLCD. Because exercise had no effect on outcome parameters (Supplementary Table 1), data of all subjects were pooled for the present analyses.","divisions":[{"label":"title","span":{"begin":0,"end":12}}],"tracks":[]}